Navigation Links
Sangamo BioSciences Announces Presentation at Lazard Capital Markets Healthcare Conference
Date:11/9/2010

RICHMOND, Calif., Nov. 9, 2010 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the progress of Sangamo's ZFP Therapeutic® development programs and an overview of the company's business strategy at 4:40 pm ET on Tuesday, November 16, 2010, at the Lazard Capital Markets 7th Annual Healthcare Conference which will be held in New York City.

A live webcast of the presentation will be available on the Sangamo BioSciences website in the Investor Relations section http://investor.sangamo.com/index.cfm under Events and Presentations. A replay of the presentation will be archived on the Sangamo website for two weeks after the event.

About Sangamo

Sangamo BioSciences, Inc. is focused on research and development of novel DNA-binding proteins for therapeutic gene regulation and modification.  The most advanced ZFP Therapeutic® development program is currently in a Phase 2b clinical trial for evaluation of safety and clinical effect in patients with diabetic neuropathy and a Phase 2 trial in ALS. Sangamo also has a Phase 1 / 2 clinical trial and two ongoing Phase 1 clinical trials to evaluate safety and clinical effect of a treatment for HIV/AIDS as well as a Phase 1 trial of a treatment for recurrent glioblastoma multiforme. Other therapeutic development programs are focused on Parkinson's disease, monogenic diseases, neuropathic pain and nerve regeneration.  Sangamo's core competencies enable the engineering of a class of DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs).  By engineering ZFPs that recognize a specific DNA sequence Sangamo has created ZFP transcription factors (ZFP TF) that can control gene expression and, consequently, cell function.  Sangamo is also
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
2. Sangamo BioSciences Announces Completion of Enrollment of Phase 2 Clinical Trial of ZFP Therapeutic for Diabetic Neuropathy
3. Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results
4. Sangamo BioSciences and Sigma-Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of Knock-Out Cell Lines
5. Sangamo BioSciences Announces Presentation of Data on ZFP Therapeutic for Glioblastoma at American Association for Cancer Research (AACR) Meeting
6. Sangamo BioSciences Provides Update on Diabetic Neuropathy Clinical Programs
7. Sangamo BioSciences Announces Presentation of Phase 1b ZFP Therapeutic Data at American Diabetes Association Meeting
8. Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells
9. Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS)
10. Sangamo BioSciences Provides Update on Companys 2008 Progress and 2009 Objectives
11. Sangamo BioSciences Announces Presentations at Two Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... July 28, 2014 Reportbuyer.com has added a ... Densitometers Market 2014-2018 https://www.reportbuyer.com/product/2225723/Global-Bone-Densitometers-Market-2014-2018.html ... scan is a special type of X-ray test used ... is used primarily to detect osteopenia or osteoporosis, diseases ... risk of fractures is high. The purpose of bone ...
(Date:7/28/2014)... , July 28, 2014 Reportlinker.com announces ... in its catalogue: Portugal Pharmaceuticals ... http://www.reportlinker.com/p0207141/Portugal-Pharmaceuticals-and-Healthcare-Report-Q3-2014.html Includes ... View: Faster-than-expected economic growth last quarter has led ... slightly upwards. As forecast previously, BMI expects ...
(Date:7/28/2014)... NORWALK, Conn. , July 28, 2014  UBM ... , a leading online community for medical imaging professionals, ... value in value-based payment models . The ... in identifying how the radiologist,s reimbursement is determined ... article features insight from leaders in the field, who ...
Breaking Medicine Technology:Global Bone Densitometers Market 2014-2018 2Global Bone Densitometers Market 2014-2018 3Global Bone Densitometers Market 2014-2018 4Global Bone Densitometers Market 2014-2018 5Portugal Pharmaceuticals and Healthcare Report Q3 2014 2Portugal Pharmaceuticals and Healthcare Report Q3 2014 3Portugal Pharmaceuticals and Healthcare Report Q3 2014 4Diagnostic Imaging Delves into Measuring the Radiologist's Value 2
... Calif., July 15, 2011 Amgen (NASDAQ: ... States (U.S.) District Court in Pennsylvania has entered ... Pharmaceutical Industries Ltd. and Teva Pharmaceuticals USA prohibiting ... G-CSF (granulocyte colony-stimulating factor) and methods for its ...
... EDISON, N.J., July 15, 2011 Crestor ... designed to lower "bad cholesterol". Both drugs are classified ... inhibiting HMG-CoA reductase. This group of drugs has had ... to Crestor and Zocor, touted as a "super statin" ...
Cached Medicine Technology:Amgen Resolves G-CSF Patent Litigation With Teva 2Crestor and Zocor Drugs Linked to Muscle Degeneration, Rhabdomyolysis 2
(Date:7/29/2014)... (PRWEB) July 29, 2014 Gout was one ... lifestyles have proven that last statement essentially moot since ... many people still do not have are the resources to ... is it costly to maintain treatment for it, but the ... daily activities to a grinding halt. , Alternative ...
(Date:7/29/2014)... 2014 Couples rule at Maui's only Forbes ... This September through November, the focus is on activities ... couples of all ages and interests. Best of all, ... of the Resort's popular Experience More package , with ... sale" is in full swing in the award-winning restaurants, spa ...
(Date:7/29/2014)... his latest blog post at http://www.perwickstrom.com , entrepreneur, author, ... 6 ways to light the “fire” in employees. , “Employers ... for some it’s a losing battle,” commented Per Wickstrom ... help employees get to the next level; which not only ... to Per Wickstrom, 6 ways to light the “fire” in ...
(Date:7/29/2014)... Nuanced Media, a leading digital marketing ... (Health Insurance Portability and Accountability Act) certified firm. ... and transfer of Personal Health Information (PHI). By ... Media can effectively serve their medical industry clients. , ... offer medical industry specific products such as medical ...
(Date:7/28/2014)... July 29, 2014 Treat skin to a ... Sublime Beauty®. , Today and tomorrow only (while supplies last), ... "The cleanser is ideal for two specific users: , 1) ... unclogged and bacteria free, and , 2) aging skin to ... says Kathy Heshelow, founder of Sublime Beauty®. , Those with ...
Breaking Medicine News(10 mins):Health News:Gout Natural Remedy Report Review | The Ultimate Secret to Eliminating Gout Naturally – Vinamy.com 2Health News:Four Seasons Resort Maui at Wailea Goes All Out to Give Couples Memorable Get-Away this Fall at Maui’s Luxury Resort 2Health News:Four Seasons Resort Maui at Wailea Goes All Out to Give Couples Memorable Get-Away this Fall at Maui’s Luxury Resort 3Health News:Per Wickstrom’s Latest Blog Post Lists 6 Ways to Light the “Fire” in Employees 2Health News:Nuanced Media Web Design Agency Now Hipaa Certified 2Health News:Clear, Clean Skin With the New Salicylic Wash from Sublime Beauty®; Enlivens Skin, Unclogs Pores 2
... DOMA Vector and DOMA Technologies to provide Record Conversion Services to more ... the Pacific. DOMA will convert millions of veteran treatment records from ... service to our veterans while reducing cost. , ... Virginia Beach, Va. ...
... DIEGO, May 7 Brandes Investment Partners, L.P. ("Brandes") ... submitted to Mitsui Sumitomo Insurance Group Holdings, Inc. (the ... on the Tokyo Stock Exchange, a proposal for a ... at the Company,s upcoming annual meeting of shareholders. ...
... weathering recession at national ALFA conferencePHILADELPHIA , ... executives today expressed confidence in the state of ... the conclusion of a national conference here.The executives ... far better than other businesses because it had ...
... Mobilization Campaign Urges Congress to Make Health Reform Work ... Hospital at Stanford is joining the National ... to launch a grassroots mobilization campaign asking Congress and ... for children. "Our hospital is extraordinarily proud ...
... WASHINGTON, May 7 The following is ... of the American Health Care Association (AHCA), Dave Kyllo, ... (NCAL) and Alan G. Rosenbloom, President of the Alliance ... the Obama Administration,s commitment to creating new jobs and ...
... May 7 Acting in response to concerns about ... Hotels and Resorts (TM), a privately held operator ... North America and Europe, today announced a three-phase program ... and provide reassurance about the safety of its facilities.(logo: ...
Cached Medicine News:Health News:Veterans Administration Awards Small Business' $13 Million Contract to Digitize Veterans Health Records 2Health News:Brandes Proposes 40 yen Per Share Dividend for Mitsui Sumitomo Insurance Group Holdings, Inc. Annual Meeting 2Health News:Brandes Proposes 40 yen Per Share Dividend for Mitsui Sumitomo Insurance Group Holdings, Inc. Annual Meeting 3Health News:Brandes Proposes 40 yen Per Share Dividend for Mitsui Sumitomo Insurance Group Holdings, Inc. Annual Meeting 4Health News:Brandes Proposes 40 yen Per Share Dividend for Mitsui Sumitomo Insurance Group Holdings, Inc. Annual Meeting 5Health News:Brandes Proposes 40 yen Per Share Dividend for Mitsui Sumitomo Insurance Group Holdings, Inc. Annual Meeting 6Health News:Senior Living Executives Optimistic About Future 2Health News:Lucile Packard Children's Hospital at Stanford to Raise Its Voice for Kids in Health Care Reform Debate 2Health News:Lucile Packard Children's Hospital at Stanford to Raise Its Voice for Kids in Health Care Reform Debate 3Health News:Joint Statement from AHCA, NCAL, and the Alliance on the Obama Administration's FY 2010 Budget 2Health News:Dolce Hotels and Resorts Initiates Program to Mitigate H1N1 Flu Risk 2
The Biopro Cox comb cup is manufactured from titanium and is porous coated on the outside of the shell. The Cox comb cup accommodates a polyethylene insert....
The Plasmacup SC satisfies two important requirements: high primary stability and a low friction bearing surface....
... The integration of Trabecular Metal ... proven implant design results in a ... not only meets surgeon demands for ... provides a wide variety of shell ...
The cementless BiHAPro cup combines proven concepts with the latest innovations in cementless THR....
Medicine Products: